Institutional-Grade Regulatory Audit for Investors
- May 7, 2026
- healthitconsult
- 0
The HealthTech equivalent of a code audit—independent FDA due diligence.
The Gap in MedTech Investment Strategy
Venture Capital (VC) and Private Equity (PE) firms investing in digital health often lack a reliable, independent method to verify a startup’s regulatory claims. Currently, most investors rely on founder self-reporting, which is systematically optimistic regarding:
FDA Pathway Timelines: Often underestimated by months or years.
Evidence Requirements: Frequently simplified in pitch decks.
Warning-Letter Exposure: Risks that are often minimized or ignored.
Without Digital Health Due Diligence, you aren’t just investing; you are assuming unquantified regulatory risk.
The Service: High-Velocity FDA Regulatory Risk Assessment
We provide a short-turnaround (1–2 week) regulatory due diligence report specifically designed for investors evaluating a digital health deal. Our audit provides the “Go/No-Go” clarity required during the deal cycle.
Critical Questions Our Report Answers:
Realistic Pathways: Is the claimed FDA pathway actually achievable for this specific product?
Classification Risk: Is this genuinely a “wellness product,” or is it a de facto medical device?
Clinical Defensibility: Are the evidence claims defensible under current published standards?
“Kill” Risks: What specific regulatory hurdles could impair or bankrupt this company?
True Costs: What is the actual budget and timeline required to achieve clearance from its current status?
Ensuring Digital Health Compliance for Top-Tier Portfolios
Our service is built for the rigorous standards of leading investment firms and strategic corporate partners.
Target Customers:
VC and Growth Equity Firms: Designed for firms with active digital health portfolios, including those evaluating pre-deal companies.
Strategic Corporate VC Arms: Providing deep-dive analysis for entities like Philips Ventures, Cigna Ventures, and Kaiser Permanente Ventures.
Secure Your Investment Today
Don’t rely on optimism. Get an independent, expert Regulatory Audit for Investors to validate your next digital health deal.